Page last updated: 2024-08-17

uridine monophosphate and Bone Marrow Diseases

uridine monophosphate has been researched along with Bone Marrow Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aradi, J; Benkő, I; Géresi, K; Megyeri, A; Németh, J; Szabó, B; Szabó, Z	1

Other Studies

1 other study(ies) available for uridine monophosphate and Bone Marrow Diseases

Article	Year
Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:3 Topics: Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Doxorubicin; Fluorouracil; Granulocyte-Macrophage Progenitor Cells; Male; Mice; Mice, Inbred C57BL; Neutropenia; Obesity; Thionucleotides; Uridine Monophosphate	2015

Article

Year

Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus.

Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:3

Topics: Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Doxorubicin; Fluorouracil; Granulocyte-Macrophage Progenitor Cells; Male; Mice; Mice, Inbred C57BL; Neutropenia; Obesity; Thionucleotides; Uridine Monophosphate

2015